nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Rash generalised—Paclitaxel—ovarian cancer	0.0324	0.0324	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—ovarian cancer	0.0275	0.0275	CcSEcCtD
Carteolol—Respiratory failure—Topotecan—ovarian cancer	0.0244	0.0244	CcSEcCtD
Carteolol—Keratitis—Paclitaxel—ovarian cancer	0.0213	0.0213	CcSEcCtD
Carteolol—Respiratory failure—Vinorelbine—ovarian cancer	0.0209	0.0209	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—ovarian cancer	0.0199	0.0199	CcSEcCtD
Carteolol—Asthenia—Altretamine—ovarian cancer	0.0194	0.0194	CcSEcCtD
Carteolol—Dizziness—Altretamine—ovarian cancer	0.0179	0.0179	CcSEcCtD
Carteolol—Eye irritation—Paclitaxel—ovarian cancer	0.0161	0.0161	CcSEcCtD
Carteolol—Nausea—Altretamine—ovarian cancer	0.0161	0.0161	CcSEcCtD
Carteolol—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.0152	0.0152	CcSEcCtD
Carteolol—Lacrimation increased—Paclitaxel—ovarian cancer	0.015	0.015	CcSEcCtD
Carteolol—Bronchospasm—Melphalan—ovarian cancer	0.0145	0.0145	CcSEcCtD
Carteolol—Atrioventricular block—Paclitaxel—ovarian cancer	0.0142	0.0142	CcSEcCtD
Carteolol—Respiratory failure—Paclitaxel—ovarian cancer	0.014	0.014	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—ovarian cancer	0.0137	0.0137	CcSEcCtD
Carteolol—Lacrimation—Epirubicin—ovarian cancer	0.0134	0.0134	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—ovarian cancer	0.0127	0.0127	CcSEcCtD
Carteolol—Bronchospasm—Vinorelbine—ovarian cancer	0.0127	0.0127	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—ovarian cancer	0.0124	0.0124	CcSEcCtD
Carteolol—Keratitis—Epirubicin—ovarian cancer	0.0122	0.0122	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—ovarian cancer	0.0119	0.0119	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—ovarian cancer	0.0112	0.0112	CcSEcCtD
Carteolol—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.011	0.011	CcSEcCtD
Carteolol—Visual disturbance—Paclitaxel—ovarian cancer	0.0106	0.0106	CcSEcCtD
Carteolol—Arrhythmia—Melphalan—ovarian cancer	0.0105	0.0105	CcSEcCtD
Carteolol—Hypoglycaemia—Paclitaxel—ovarian cancer	0.0103	0.0103	CcSEcCtD
Carteolol—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.0102	0.0102	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—ovarian cancer	0.00935	0.00935	CcSEcCtD
Carteolol—Arrhythmia—Vinorelbine—ovarian cancer	0.0092	0.0092	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—ovarian cancer	0.00895	0.00895	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—ovarian cancer	0.00855	0.00855	CcSEcCtD
Carteolol—Oedema—Melphalan—ovarian cancer	0.00837	0.00837	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—ovarian cancer	0.00813	0.00813	CcSEcCtD
Carteolol—Palpitations—Vinorelbine—ovarian cancer	0.00792	0.00792	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—ovarian cancer	0.00791	0.00791	CcSEcCtD
Carteolol—Hypotension—Melphalan—ovarian cancer	0.00782	0.00782	CcSEcCtD
Carteolol—Depression—Paclitaxel—ovarian cancer	0.00769	0.00769	CcSEcCtD
Carteolol—Dyspnoea—Topotecan—ovarian cancer	0.00762	0.00762	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—ovarian cancer	0.00752	0.00752	CcSEcCtD
Carteolol—Conjunctivitis—Paclitaxel—ovarian cancer	0.0075	0.0075	CcSEcCtD
Carteolol—Dyspnoea—Melphalan—ovarian cancer	0.00746	0.00746	CcSEcCtD
Carteolol—Sinusitis—Paclitaxel—ovarian cancer	0.00724	0.00724	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—ovarian cancer	0.00721	0.00721	CcSEcCtD
Carteolol—Hypersensitivity—Chlorambucil—ovarian cancer	0.00708	0.00708	CcSEcCtD
Carteolol—Bradycardia—Paclitaxel—ovarian cancer	0.00705	0.00705	CcSEcCtD
Carteolol—Asthenia—Chlorambucil—ovarian cancer	0.00689	0.00689	CcSEcCtD
Carteolol—Hypotension—Vinorelbine—ovarian cancer	0.00683	0.00683	CcSEcCtD
Carteolol—Visual impairment—Paclitaxel—ovarian cancer	0.00667	0.00667	CcSEcCtD
Carteolol—Diabetes mellitus—Epirubicin—ovarian cancer	0.00658	0.00658	CcSEcCtD
Carteolol—Dyspnoea—Vinorelbine—ovarian cancer	0.00652	0.00652	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—ovarian cancer	0.00635	0.00635	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00631	0.00631	CcSEcCtD
Carteolol—Hypersensitivity—Topotecan—ovarian cancer	0.0063	0.0063	CcSEcCtD
Carteolol—Arrhythmia—Paclitaxel—ovarian cancer	0.00619	0.00619	CcSEcCtD
Carteolol—Hypersensitivity—Melphalan—ovarian cancer	0.00617	0.00617	CcSEcCtD
Carteolol—Asthenia—Topotecan—ovarian cancer	0.00613	0.00613	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00609	0.00609	CcSEcCtD
Carteolol—Asthenia—Melphalan—ovarian cancer	0.00601	0.00601	CcSEcCtD
Carteolol—Dysgeusia—Paclitaxel—ovarian cancer	0.0059	0.0059	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—ovarian cancer	0.00586	0.00586	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00584	0.00584	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00584	0.00584	CcSEcCtD
Carteolol—Diplopia—Epirubicin—ovarian cancer	0.00572	0.00572	CcSEcCtD
Carteolol—Nausea—Chlorambucil—ovarian cancer	0.0057	0.0057	CcSEcCtD
Carteolol—Vision blurred—Paclitaxel—ovarian cancer	0.00568	0.00568	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—ovarian cancer	0.00566	0.00566	CcSEcCtD
Carteolol—Dizziness—Topotecan—ovarian cancer	0.00565	0.00565	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00543	0.00543	CcSEcCtD
Carteolol—Syncope—Paclitaxel—ovarian cancer	0.00541	0.00541	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.0054	0.0054	CcSEcCtD
Carteolol—Hypersensitivity—Vinorelbine—ovarian cancer	0.00539	0.00539	CcSEcCtD
Carteolol—Headache—Topotecan—ovarian cancer	0.00536	0.00536	CcSEcCtD
Carteolol—Palpitations—Paclitaxel—ovarian cancer	0.00533	0.00533	CcSEcCtD
Carteolol—Loss of consciousness—Paclitaxel—ovarian cancer	0.0053	0.0053	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—ovarian cancer	0.00529	0.00529	CcSEcCtD
Carteolol—Asthenia—Vinorelbine—ovarian cancer	0.00525	0.00525	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—ovarian cancer	0.00524	0.00524	CcSEcCtD
Carteolol—Nausea—Topotecan—ovarian cancer	0.00508	0.00508	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—ovarian cancer	0.005	0.005	CcSEcCtD
Carteolol—Nausea—Melphalan—ovarian cancer	0.00497	0.00497	CcSEcCtD
Carteolol—Oedema—Paclitaxel—ovarian cancer	0.00492	0.00492	CcSEcCtD
Carteolol—Shock—Paclitaxel—ovarian cancer	0.00484	0.00484	CcSEcCtD
Carteolol—Dizziness—Vinorelbine—ovarian cancer	0.00484	0.00484	CcSEcCtD
Carteolol—Hypotension—Paclitaxel—ovarian cancer	0.0046	0.0046	CcSEcCtD
Carteolol—Headache—Vinorelbine—ovarian cancer	0.00458	0.00458	CcSEcCtD
Carteolol—Syncope—Docetaxel—ovarian cancer	0.00458	0.00458	CcSEcCtD
Carteolol—Palpitations—Docetaxel—ovarian cancer	0.00451	0.00451	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—ovarian cancer	0.00449	0.00449	CcSEcCtD
Carteolol—Insomnia—Paclitaxel—ovarian cancer	0.00445	0.00445	CcSEcCtD
Carteolol—Dyspnoea—Paclitaxel—ovarian cancer	0.00439	0.00439	CcSEcCtD
Carteolol—Nausea—Vinorelbine—ovarian cancer	0.00434	0.00434	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—ovarian cancer	0.00429	0.00429	CcSEcCtD
Carteolol—Oedema—Docetaxel—ovarian cancer	0.00417	0.00417	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—ovarian cancer	0.00414	0.00414	CcSEcCtD
Carteolol—Shock—Docetaxel—ovarian cancer	0.0041	0.0041	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—ovarian cancer	0.00403	0.00403	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.00397	0.00397	CcSEcCtD
Carteolol—Hypotension—Docetaxel—ovarian cancer	0.0039	0.0039	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—ovarian cancer	0.00383	0.00383	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—ovarian cancer	0.00381	0.00381	CcSEcCtD
Carteolol—Insomnia—Docetaxel—ovarian cancer	0.00377	0.00377	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—ovarian cancer	0.00373	0.00373	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—ovarian cancer	0.00372	0.00372	CcSEcCtD
Carteolol—Hypersensitivity—Paclitaxel—ovarian cancer	0.00362	0.00362	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—ovarian cancer	0.00354	0.00354	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Carteolol—Asthenia—Paclitaxel—ovarian cancer	0.00353	0.00353	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—ovarian cancer	0.00337	0.00337	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—ovarian cancer	0.00327	0.00327	CcSEcCtD
Carteolol—Dizziness—Paclitaxel—ovarian cancer	0.00325	0.00325	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—ovarian cancer	0.00325	0.00325	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—ovarian cancer	0.00312	0.00312	CcSEcCtD
Carteolol—Syncope—Epirubicin—ovarian cancer	0.00309	0.00309	CcSEcCtD
Carteolol—Headache—Paclitaxel—ovarian cancer	0.00308	0.00308	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—ovarian cancer	0.00307	0.00307	CcSEcCtD
Carteolol—Palpitations—Epirubicin—ovarian cancer	0.00305	0.00305	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—ovarian cancer	0.00303	0.00303	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—ovarian cancer	0.003	0.003	CcSEcCtD
Carteolol—Asthenia—Docetaxel—ovarian cancer	0.00299	0.00299	CcSEcCtD
Carteolol—Nausea—Paclitaxel—ovarian cancer	0.00292	0.00292	CcSEcCtD
Carteolol—Syncope—Doxorubicin—ovarian cancer	0.00286	0.00286	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Carteolol—Oedema—Epirubicin—ovarian cancer	0.00281	0.00281	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.0028	0.0028	CcSEcCtD
Carteolol—Shock—Epirubicin—ovarian cancer	0.00277	0.00277	CcSEcCtD
Carteolol—Dizziness—Docetaxel—ovarian cancer	0.00276	0.00276	CcSEcCtD
Carteolol—Hypotension—Epirubicin—ovarian cancer	0.00263	0.00263	CcSEcCtD
Carteolol—Headache—Docetaxel—ovarian cancer	0.00261	0.00261	CcSEcCtD
Carteolol—Oedema—Doxorubicin—ovarian cancer	0.0026	0.0026	CcSEcCtD
Carteolol—Shock—Doxorubicin—ovarian cancer	0.00256	0.00256	CcSEcCtD
Carteolol—Insomnia—Epirubicin—ovarian cancer	0.00254	0.00254	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—ovarian cancer	0.00251	0.00251	CcSEcCtD
Carteolol—Nausea—Docetaxel—ovarian cancer	0.00248	0.00248	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—ovarian cancer	0.00243	0.00243	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—ovarian cancer	0.00235	0.00235	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—ovarian cancer	0.00232	0.00232	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—ovarian cancer	0.00207	0.00207	CcSEcCtD
Carteolol—Asthenia—Epirubicin—ovarian cancer	0.00202	0.00202	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—ovarian cancer	0.00192	0.00192	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—ovarian cancer	0.00187	0.00187	CcSEcCtD
Carteolol—Dizziness—Epirubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Carteolol—Headache—Epirubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Carteolol—Nausea—Epirubicin—ovarian cancer	0.00167	0.00167	CcSEcCtD
Carteolol—Headache—Doxorubicin—ovarian cancer	0.00163	0.00163	CcSEcCtD
Carteolol—Nausea—Doxorubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
